STAT: Pursuit of profits is driving drug companies to break the 340B law

“Seventeen drug companies, including some of the world’s largest, are flouting a 30-year-old federal program that supports hospitals serving patients with low incomes and those who live in rural ...

Opinion: The 340B drug-pricing program, a critical MetroHealth patient lifeline, is under threat

“This spring, I find myself embracing the change of season and reflecting on the challenges of seasons past. For two years, we intensive-care professionals have cared for critically ill COVID-19 ...

Where Is the HHS Inspector General?

By 340B Matters So far, seven of the world’s largest drug manufacturers have been referred to the Department of Health and Human Services Office of Inspector General for blatantly ...

Recognizing the Work of Congressional Champions for America’s Health Care Safety Net

By 340B Matters As lawmakers return to their districts and states for recess, we want to applaud a bipartisan group of congressional leaders that have been staunch champions for the 340...

Townhall: Drug Pricing Program Needs Protection

“President Biden’s call during his State of the Union address for Congress to pass legislation to control drug prices provides a good opportunity to note a law that already ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields